+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AJANTPHARM

Ajanta Pharma Share Price

₹3,283.90 +13.3 (0.41%)
37.86% Gain from 52W Low

23 Oct, 2026 3:51 PM (IST)

Ajanta Pharma live price: ₹3,283.90. It opened at ₹3,261 vs previous close ₹3,271; intraday high/low: ₹3,350/₹3,224. The 50 & 200 DMA stand at ₹3,442.40/₹3,199.60.

Ajanta Pharma Performance

  • Today's Low
  • ₹3,224
  • Today's High
  • ₹3,350
  • 52 Week Low
  • ₹2,382
  • 52 Week High
  • ₹3,796
  • Open Price₹3,261
  • Previous Close₹3,271
  • Volume160,689
  • 50 DMA₹3,442.40
  • 100 DMA₹3,372.50
  • 200 DMA₹3,199.60

Ajanta Pharma Chart

Investment Returns

  • Over 1 Month -7.22%
  • Over 3 Month -2.54%
  • Over 6 Month + 18.75%
  • Over 1 Year + 36.01%

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.2
  • PEG Ratio
  • 1.6
  • Market Cap Cr
  • 41,035
  • P/B Ratio
  • 8.4
  • Average True Range
  • 96.1
  • EPS
  • 90.8
  • Dividend Yield
  • 1.8
  • MACD Signal
  • -68.7
  • RSI
  • 36.14
  • MFI
  • 39.31

Latest Stock News Updates

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 19, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pls find enclosed Earnings Conference Call Intimation.

Ajanta Pharma Ltd - 532331 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027

Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹3,283.90
+ 13.3 (0.41%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹3,395.20
  • 50 Day
  • ₹3,442.40
  • 100 Day
  • ₹3,372.50
  • 200 Day
  • ₹3,199.60

Resistance and Support

3285.93 Pivot Speed
  • R3 3,472.90
  • R2 3,411.20
  • R1 3,347.60
  • S1 3,222.30
  • S2 3,160.60
  • S3 3,097.00

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-30 Quarterly Results
2026-07-30 Quarterly Results & Interim Dividend
2026-05-05 Audited Results
2026-01-30 Quarterly Results
2025-11-03 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-08-05 INTERIM Rs.32.00 per share(1600%)First Interim Dividend
2025-11-10 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
View Ajanta Pharma Dividend History Arrow
Date Purpose Remarks
2012-08-10 Split
Date Purpose Remarks
2022-06-23 Bonus Bonus issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma Shareholding Pattern

63.47%
17.95%
7.62%
6.96%
3.99%

About Ajanta Pharma

Ajanta Pharma is primarily involved in development manufacturing and marketing of speciality pharmaceutical finished dosages.(Source : AR-PDF:202603-01 Pg No:109) View More
  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹3,283 As on 25 October, 2026 | 13:17

The Market Cap of Ajanta Pharma is ₹41035.3 Cr As on 25 October, 2026 | 13:17

The P/E ratio of Ajanta Pharma is 36.2 As on 25 October, 2026 | 13:17

The PB ratio of Ajanta Pharma is 8.4 As on 25 October, 2026 | 13:17

The 52 week High & Low of Ajanta Pharma is ₹3796/₹2382 respectively As on 25 October, 2026 | 13:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23